Ro vs Found GLP-1 Protocol: Which Provider Has Better Medical Oversight?

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Choosing between Ro and Found for GLP-1 treatment isn't just about price — it's about finding the right level of clinical oversight for your weight loss journey. Ro charges $145/month membership plus medication costs ($294-$444/month total for oral Wegovy), while Found provides video consultations with obesity medicine specialists plus behavioral coaching for $129-$199/month program fees plus separate medication costs.

Ro operates 85% faster medication delivery with standardized 4-week titration protocols, while Found provides personalized dose timing through board-certified obesity specialists with integrated behavioral coaching. For busy professionals seeking minimal hassle, Ro's streamlined approach wins. For patients wanting structured medical guidance and long-term weight maintenance support, Found delivers superior clinical outcomes.

How do Ro and Found GLP-1 protocols differ?

Protocol differences stem from opposing philosophies about patient oversight and interaction frequency.

Ro standardizes care delivery. Patients complete online assessments and receive medication within 3-5 days. Titration follows FDA schedules: 0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg for injectable semaglutide over 16-20 weeks. All contact happens through patient-initiated messaging.

Found personalizes treatment timing. Board-certified obesity physicians conduct 30-45 minute video consultations, then create individualized treatment plans. Follow-up visits occur at clinical milestones. Dose adjustments happen during video consultations based on individual response patterns.

The protocol intensity reflects different philosophies: Ro prioritizes speed and simplicity for straightforward cases, while Found emphasizes comprehensive care for patients needing behavioral support alongside medication.

Protocol Element	Ro	Found
Initial consultation	Async questionnaire	Video consultation (30-45 min)
Prescriber type	MD/NP generalists	Board-certified obesity medicine physicians
Titration schedule	4-week intervals (standard FDA)	Personalized adjustments during video visits
Follow-up model	Patient-initiated messaging	Scheduled video consultations
Behavioral support	None (medication only)	Integrated coaching and community

Pricing last verified April 2026. We update pricing data monthly.

What are the titration schedule differences between Ro and Found?

Both providers follow FDA-approved titration protocols, but their oversight approaches create different patient experiences during dose escalation.

Ro uses standard 4-week titration intervals for all patients. Injectable semaglutide starts at 0.25mg weekly, escalating every 4 weeks: 0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg maintenance dose. Oral Wegovy follows a different schedule: 3mg daily → 7mg → 14mg → 25mg maintenance. Patients receive dosing instructions with each shipment and manage escalation through async messaging.

Found personalizes titration timing based on individual response and tolerance. While the dose ladder remains the same (FDA-mandated), timing between escalations can be adjusted during video consultations. Patients showing strong response at lower doses might stay longer before increasing. Those tolerating medication well with minimal side effects might escalate slightly faster.

The practical difference: Ro patients follow a fixed schedule regardless of individual response, while Found patients receive timing adjustments based on clinical assessment during video visits.

Medication	Ro Schedule	Found Schedule
Injectable semaglutide	0.25→0.5→1.0→1.7→2.4mg (4 weeks each)	Same doses, personalized timing
Oral Wegovy	3→7→14→25mg (4 weeks each)	Same doses, adjusted based on tolerance
Tirzepatide (Zepbound)	2.5→5→7.5→10→12.5→15mg (4 weeks each)	Same doses, individualized progression

Clinical data from SURMOUNT-5 shows patients achieving 15.7% mean weight loss at 12 months with tirzepatide, while semaglutide delivers 10.9% weight loss in head-to-head comparisons. Both providers follow identical FDA-approved dosing ladders, but Found's personalized timing approach allows for tolerance-based adjustments that may improve long-term adherence.

How do monitoring requirements compare between Ro and Found?

The monitoring frequency and depth differ significantly between these providers, reflecting their different care models.

Ro operates on patient-initiated contact only. No scheduled follow-ups occur after initial prescription. Patients message their provider for dose escalation approval, side effect concerns, or clinical questions. Response times are typically within 24 hours, but no proactive monitoring happens. No lab work is required or offered at any point during treatment.

Found incorporates structured monitoring through video consultations. While not as intensive as specialty clinic programs, Found schedules periodic video visits to assess progress, adjust medications, and address concerns. The exact frequency varies by provider and patient needs, but typically occurs at key milestones: initial consultation, early titration phases, and when reaching maintenance doses.

Neither provider requires baseline lab work, which differs from comprehensive programs like Calibrate that mandate metabolic panels before treatment. Patients with complex medical histories should arrange independent lab testing with their primary care physician.

The monitoring gap affects different patients differently. Self-directed patients often prefer Ro's hands-off approach, while those with previous weight loss struggles benefit from Found's structured check-ins.

What are the cost differences between Ro and Found GLP-1 programs?

Total program costs reveal significant differences due to restructured pricing models in 2026, making careful comparison essential for budget-conscious patients.

Ro charges membership fees plus separate medication costs. The Ro Body membership costs $145/month for all clinical services. Oral Wegovy costs $149-$299/month for medication, creating total costs of $294-$444/month. Injectable Wegovy costs $1,349/month without insurance. Compounded semaglutide appears discontinued from their current offerings.

Found charges program fees plus separate medication costs. The Core plan costs $129/month, Plus plan costs $199/month cash-pay or $49/month with insurance. Medication costs are separate: injectable Wegovy starts at $650/month, oral options vary by dose. Total monthly costs range from $178-$848/month depending on plan and medication selection.

Both providers eliminated "all-inclusive" pricing in 2026, now requiring separate fees plus medication costs. Ro totals $294-$444/month, while Found ranges $178-$848/month depending on plan selection.

Found's higher program fees include video consultations with obesity medicine specialists and behavioral coaching. Ro's membership focuses solely on medication delivery and async provider access. Value depends on whether patients engage actively with behavioral support services.

Cost Component	Ro (April 2026)	Found (April 2026)
Program/membership fee	$145/mo	$129/mo (Core) or $199/mo (Plus)
Oral Wegovy	$149-$299/mo + membership	Varies by dose + program fee
Injectable Wegovy	$1,349/mo + membership	$650+/mo + program fee
Insurance support	Basic PA assistance	Comprehensive advocacy
Total monthly cost range	$294-$1,494/mo	$178-$848/mo

How do patient support models differ between Ro and Found?

The support infrastructure represents the largest philosophical difference between these providers, affecting both treatment success and patient satisfaction.

Ro provides medication-focused support only. Unlimited async messaging with licensed providers covers dose adjustments, side effect management, and clinical questions. No behavioral coaching, nutrition guidance, or community support is included. The Body program includes basic metabolic health information but no structured coaching component.

Found integrates behavioral support throughout treatment. Board-certified obesity medicine physicians collaborate with behavioral coaches to address eating patterns, stress management, sleep optimization, and physical activity. Community forums connect patients with similar goals. Educational content covers nutrition strategies, lifestyle modifications, and long-term weight maintenance.

The support difference matters most for long-term outcomes. Research shows 67% of patients regain weight within one year of stopping GLP-1 medications (STEP 1 extension data). Found's behavioral approach directly addresses this challenge, while Ro focuses solely on medication access during active treatment.

For self-directed patients: Ro's streamlined approach eliminates unnecessary coaching touchpoints and focuses on efficient medication delivery.

For patients needing guidance: Found's comprehensive support addresses the behavioral components essential for sustainable weight loss beyond medication.

What are the prescription fulfillment differences?

Shipping speed and medication sourcing create practical differences in treatment initiation and ongoing access.

Ro ships medications within 3-5 business days from 503B-registered compounding pharmacies for compounded medications or through retail partnerships for brand medications. Free shipping is included. Automatic refills ensure continuity. Supply chain reliability is strong due to Ro's scale and established pharmacy relationships.

Found ships medications within 5-7 business days — slower than most competitors. Brand medications go through retail or specialty pharmacies. Shipping is included in program costs. The longer timeline can frustrate patients eager to start treatment, particularly those transitioning from other providers.

For urgent treatment initiation, Ro's faster shipping provides a meaningful advantage. Patients switching from compounded to branded medications or starting treatment for the first time often prioritize speed over comprehensive support during the initial weeks.

Fulfillment Element	Ro	Found
Shipping time	3-5 business days	5-7 business days
Medication sourcing	503B compounding + retail	Retail and specialty pharmacies
Shipping cost	Free	Included in program
Refill management	Automatic	Managed through platform

Which provider offers better clinical depth?

Clinical depth encompasses prescriber qualifications, assessment thoroughness, and ongoing medical oversight — areas where Found holds clear advantages.

Found employs board-certified obesity medicine physicians who specialize in weight management and understand the complex biology of metabolic health. Initial assessments include behavioral evaluation alongside medical screening. Video consultations allow for visual assessment and detailed discussion of treatment goals, previous weight loss attempts, and lifestyle factors.

Ro uses licensed physicians and nurse practitioners who are generalists rather than obesity specialists. Assessment occurs through online questionnaires without visual consultation. While clinically competent for straightforward GLP-1 prescribing, the model provides less depth for complex cases or patients with multiple comorbidities.

Neither provider requires baseline lab work, which limits comprehensive metabolic assessment. Patients with diabetes, cardiovascular risk factors, or thyroid conditions should arrange independent testing regardless of provider choice.

Complex cases with multiple comorbidities benefit from Found's obesity medicine specialists and comprehensive assessment. Healthy patients seeking basic GLP-1 access find Ro's generalist model adequate.

How do side effect management approaches compare?

GLP-1 medications commonly cause nausea, vomiting, and gastrointestinal symptoms, making side effect management protocols crucial for treatment success.

Ro handles side effects through async messaging. Patients experiencing symptoms message their provider for guidance on dose holds, anti-nausea medications, or dietary modifications. Standard advice includes holding dose escalation if symptoms are significant and implementing basic dietary changes (smaller portions, lower fat content). No structured antiemetic protocol is documented publicly.

Found addresses side effects through integrated behavioral coaching. Nutrition guidance covers meal timing, portion sizes, and food choices that minimize GI symptoms. Behavioral coaches help patients identify trigger foods and develop coping strategies. Video consultations allow providers to assess symptom severity and make real-time adjustments to treatment plans.

The behavioral component at Found provides practical advantages for side effect management. Coaches teach specific strategies: eating slowly, avoiding high-fat meals, managing meal timing around doses, and distinguishing between normal GLP-1 effects and concerning symptoms requiring medical attention.

Patients experiencing severe nausea or vomiting benefit from Found's behavioral coaching combined with medical oversight. Those with minimal symptoms find Ro's messaging-based approach sufficient.

What insurance coverage differences exist?

Insurance navigation and coverage support vary between providers, affecting total out-of-pocket costs for branded medications.

Ro added insurance support in 2025 to help patients access brand Wegovy and Zepbound through coverage. They assist with prior authorization paperwork and coverage verification but don't handle complex appeals or multi-step authorization processes. Most patients pay cash for branded medications given current pricing structures.

Found specializes in insurance navigation for branded GLP-1 medications. Their team assists with prior authorizations, coverage verification, and appeals processes when initial requests are denied. For Medicare patients, Found supports access to GLP-1 medications through the Medicare Bridge Program (pending implementation) at approximately $50/month copays.

Insurance success rates depend more on individual policy coverage than provider advocacy. Both providers can submit paperwork and follow up with insurers, but ultimate approval depends on policy terms and medical necessity documentation.

For patients with good insurance coverage: Found's more comprehensive insurance support provides better advocacy through complex approval processes.

For cash-pay patients: Ro's transparent pricing eliminates insurance complexity entirely.

Which provider is better for specific patient types?

Patient characteristics should drive provider selection, as each model serves different needs effectively.

Ro works best for:

• Self-directed patients comfortable managing their own treatment
• Patients wanting 3-5 day medication delivery without consultations
• Busy professionals preferring minimal provider contact
• Those with straightforward cases and no complex medical histories

Found works best for:

• Patients wanting comprehensive support beyond medication alone
• Individuals with previous weight loss struggles or weight cycling history
• Those preferring video consultations with obesity medicine specialists
• Patients concerned about weight regain after medication discontinuation
• People who will actively engage with coaching and behavioral support

For first-time GLP-1 users: Found's structured approach and specialist care provide better foundation for treatment success.

For experienced patients: Ro's streamlined model offers efficiency without unnecessary support layers.

How do these providers compare to other GLP-1 platforms?

Understanding Ro and Found's position relative to other telehealth providers helps contextualize their strengths and limitations.

Versus budget providers (Henry Meds, Hims): Ro matches Henry Meds' $149/month pricing while offering broader medication options. Found costs more but provides significantly more clinical depth and support than budget platforms.

Versus premium programs (Calibrate, Sequence): Found bridges the gap between budget and premium providers, offering obesity specialists and coaching without Calibrate's $199/month program fee and year-long commitment. Ro focuses purely on medication access without the comprehensive clinical model of premium programs.

Versus specialty clinics: Neither provider matches the clinical depth of dedicated weight management clinics with endocrinologists, but both offer greater accessibility and faster treatment initiation than traditional medical settings.

The telehealth GLP-1 market has largely segmented into three tiers: budget medication access (Ro, Henry Meds), comprehensive support (Found, Calibrate), and premium clinical programs (Sequence, specialty clinics).

Frequently Asked Questions

Is Ro or Found better for GLP-1 protocol management? Found offers superior protocol management through board-certified obesity medicine physicians, video consultations, and personalized titration adjustments. Ro provides adequate protocol management for straightforward cases through async messaging with licensed providers. Patients needing intensive oversight should choose Found; those wanting minimal provider contact should choose Ro.

Which provider has faster medication shipping? Ro ships medications in 3-5 business days versus Found's 5-7 business days. For patients eager to start treatment, Ro's faster fulfillment provides a meaningful advantage, especially when switching providers or beginning treatment for the first time.

Do Ro and Found require lab work before prescribing GLP-1? Neither provider requires baseline lab work as a standard part of enrollment. Found's obesity medicine physicians may recommend labs during video consultations based on individual assessment, while Ro's async model typically doesn't include lab discussions unless patients specifically ask.

What's the total monthly cost difference between Ro and Found? Ro costs $145/month membership plus medication costs ($294-$444/month total for oral Wegovy). Found costs $129-$199/month program fees plus medication costs ($178-$848/month total range). Both providers eliminated all-inclusive pricing in 2026, requiring separate fees plus medication costs for all patients.

Which provider offers better side effect support? Found provides better side effect management through integrated behavioral coaching, nutrition guidance, and video consultations that allow real-time assessment. Ro handles side effects through async messaging, which is adequate for patients with minimal symptoms but less comprehensive for severe reactions.

Can I switch between Ro and Found during treatment? Yes, patients can switch providers during GLP-1 treatment. Medical records and dosing history transfer between providers. Switching may require brief treatment interruptions while new providers review medical history and establish care protocols.

Which provider has better insurance support for brand medications? Found offers more comprehensive insurance navigation, including appeals support and Medicare Bridge Program assistance. Ro provides basic prior authorization help but focuses primarily on cash-pay options. Patients with complex insurance situations benefit from Found's more intensive advocacy.

Do these providers offer non-GLP-1 weight loss medications? Found maintains a broader formulary including non-GLP-1 weight management medications for patients unable to access GLP-1s. Ro focuses exclusively on GLP-1 medications (semaglutide, tirzepatide, orforglipron) and doesn't offer alternative weight loss drugs.

---

Bottom Line: For busy professionals seeking minimal-hassle GLP-1 access with fastest delivery, Ro wins with 3-5 day shipping and standardized protocols, though total costs range $294-$444/month. For patients wanting comprehensive medical oversight, behavioral coaching, and long-term weight maintenance support, Found provides better clinical outcomes with obesity specialists and costs ranging $178-$848/month.

Choose Ro if you prioritize speed, standardized care, and minimal provider interaction. Choose Found if you value clinical depth, behavioral support, and personalized treatment planning with specialist oversight.